引用本文:孟宪璞,肖丽梅,张素霞,李静,李开丽,连丽英,安国辉.郭连澍教授经验方“丹栀通竹方”治疗中风后抑郁症的临床研究[J].世界中医药,2017,(04):. |
|
郭连澍教授经验方“丹栀通竹方”治疗中风后抑郁症的临床研究 |
Clinical Study of “Danzhi Tongzhu” in the Treatment of Post-stroke Depression |
投稿时间:2017-01-06 |
DOI:10.3969/j.issn.1673-7202.2017.04.032 |
中文关键词: 丹栀通竹方 中风 抑郁 BDNF |
English Keywords:Danzhi Tongzhu Stroke Depression BDNF |
基金项目:河北省中医药管理局科研计划(编号:20140154) |
|
摘要点击次数: 1331 |
全文下载次数: 1233 |
中文摘要: |
目的:观察关“丹栀通竹方”治疗中风后抑郁症的临床。方法:选取2015年3月至2016年2月新乐市中医医院针灸科、康复科门诊、中风病病房收治的60例中风后抑郁患者,按就诊顺序编随机数字表法进行随机分为治疗组和对照组,每组30例。对照组在内科常规治疗基础上,口服盐酸氟西汀(20 mg,1次/d,治疗组在内科常规治疗基础上给予丹栀通竹方加减治疗。治疗前、治疗30 d和治疗60 d采用Fugl-Mayer评估量表(FMA)量表评估患者的偏瘫肢体运动功能;汉密顿抑郁量表(HAMD)量表评分对中风后患者进行抑郁评分评估;运用改良日常生活活动量表(mBI)评分以评估患者的生活质量及采用酶联免疫吸附试验(ELISA)检测脑源性神经营养因子(BDNF)。结果:2组治疗后FMA、mBI评分和BDNF均高于治疗前(P<0.05);与对照组比较,治疗组治疗30 d的FMA、mBI评分和BDNF均差异无统计学意义(P>0.05),治疗60 d的FMA、mBI评分和BDNF均较高(P<0.05)。HAMD评分结果与之相反,BDNF的表达情况与HAMD量表评分呈负相关,Pearson相关系数为-0.949,P=0.000<0.05。结论:丹栀通竹方可明显改善PSD抑郁症状,并因此更进一步协助患者躯体功能恢复,而该方发挥疗效可能与上调BDNF有关。 |
English Summary: |
To observe the effect of “Danzhi Tongzhu” in clinical treatment of depression after stroke. Methods:A total of 60 patients with post-stroke depression admitted in departments of acupuncture, rehabilitation and stroke disease of Xinle Hospital of Traditional Chinese Medicine from March 2015 to February 2016 were randomly divided into a treatment group and a control group according to the order of visits, with 30 patients in each group. Patients in the control group were given oral administration of fluoxetine hydrochloride (20 mg, 1 times a day) on the basis of routine medical treatment, while patients in the treatment group were given Danzhi Tongzhu on the same basis. Before treatment, 30 days and 60 days after treatment, Fugl-Mayer assessment scale (FMA) was used to assess the motor function of hemiplegic limbs of patients; the Hamilton depression scale (HAMD) was used to evaluate the depression of patients; activities of daily living scale (mBI) was used to assess the quality of life of patients and enzyme-linked immunosorbent assay (ELISA) was used to detect the patients’ brain-derived neurotrophic factor (BDNF). Results:After treatment, the FMA, mBI score and BDNF were all higher than those before treatment (P<0.05). Compared with the control group, there was no statistically significant difference in the FMA, mBI score and BDNF in the treatment group (P>0.05) 30 days after treatment, while 60 days after treatment, the FMA, mBI score and BDNF were higher (P<0.05). By contrast, the HAMD score was negatively correlated with the BDNF expression and the HAMD scale score, and the correlation coefficient of Pearson was-0.949, P=0.000<0.05. Conclusion:Danzhi Tongzhu can significantly improve PSD symptoms of depression, and therefore further assist patients with recovery of body function, and the effect may be related to the increase in BDNF. |
查看全文 查看/发表评论 下载PDF阅读器 |